Market Review: October 28, 2022

Auto PostDaily Market Report

Closing Recap

Friday, October 28, 2022

Index

Up/Down

%

Last

DJ Industrials

828.06

2.59%

32,861

S&P 500

93.73

2.46%

3,901

Nasdaq

309.78

2.87%

11,102

Russell 2000

40.14

2.22%

1,846


 

Equity Market Recap

·     US equities enjoyed a nice bounce with both S&P and NASDAQ up more than 2%. AAPL earnings stood out last night for not hugely disappointing investors as other tech names have recently, and the stock pulled the market higher with a nice rally today. In-line core PCE data also failed to spook investors and supported the move higher in equities with breadth a bit better than 2:1 in favor of gainers. October has thus far outperformed to the upside and investors seem once again to be looking for reasons to believe in a Fed pivot, or at least an easing of rate increases, on the not-too-distant horizon (perhaps a bit optimistic at this point). From a data perspective, though, there is reason to be more bullish than bearish, at least in the near term. Over the last six instances, the S&P 500 has averaged a gain of 7.3% with a median gain of 5.8% in the period between a 2s/10s yield curve inversion and the start of recession. Just something to consider.

·     On a sector ETF basis, only Consumer Discretionary (XLY) was lower and that really was just a function of AMZN’s decline and weighting in the ETF. Equally weighted, Consumer Discretionary performance was more than +1.5%. Sector leaders on the day were Technology (XLK) +4.3% thanks to AAPL’s big day, Communications (XLC) better than +2% on TMUS, GOOGL and VZ strength and Utilities (XLU). Both value and growth gained better than 2% with growth modestly outperforming The Dow remains on track for a 14% advance in October – would be the biggest monthly gain since January 1987.

 

Economic Data:

·     U.S. Q3 employment cost index (ECI) rose +1.2%, in-line with estimates and down from +1.3% in Q2; Q3 wages/salaries +1.3% vs Q2 +1.4% and Q3 benefit costs +1.0% vs Q2 +1.2%

·     Personal Income rose +0.4% m/m vs. +0.3% expected and +0.4% prior while Personal spending rose +0.6% m/m vs. +0.4% expected and +0.6% prior; Sept personal saving rate 3.1% vs Aug 3.4%

·     PCE Price Index for Sept rises +0.3% m/m, in-line with consensus and +0.3% prior while rises +6.2% y/y vs. +6.3% expected and +6.2% prior

·     Core PCE Price Index for Sept rises +0.5% m/m vs. +0.5% expected and +0.5% prior and rises +5.1% y/y vs. +5.2% expected and +4.9% prior.

·     University of Michigan surveys of consumers sentiment final Oct 59.9 mostly in-line with consensus 59.8; University of Michigan surveys of consumers 1-year inflation outlook final oct 5.0% vs prelim 5.1% and final sept 4.7%; current conditions index final oct 65.6 vs prelim oct 65.3 and expectations index final oct 56.2 vs prelim oct 56.2 and final sept 58.0

·     Sept Pending Home sales index -10.2% vs. est. (-5.0%) to 79.5; Sept Pending Home sales -31.0% from Sept 2021

 

Commodities

·     Oil prices fell with WTI crude -$1.18 or 1.32% to settle at $87.90 per barrel while Brent dropped -$1.19 or 1.23% to settle at $95.77 per barrel as a bounce in the U.S. dollar weighed on commodity prices, while COVID-19 restrictions in China renewed concerns about energy demand. Still, prices still ended the week higher with WTI crude rising 3.4%, its first gain in 3-weeks. Gold prices slide -$20.80 or 1.25% at $1,644.80 an ounce. Natural gas for December delivery fell 19.1c, or 3.3%, to settle at $5.684 per million British thermal units (MMBtu). For the week, the contract was on track to gain about 15% after plunging about 23% last week. That would be its first weekly gain in 10 weeks

 

Currencies & Treasuries

·     Treasury yields advanced across the curve on Friday as data showed that a key gauge of U.S. inflation favored by policy makers rose sharply in September. The 2-year yield rose 10-bps today, but overall declined 6.7 bps this week to 4.422%, down now 2-straight weeks; The 10-year yield rose 7 bps today, but declined 20.3 bps this week to 4.009%, snapping a 12-week winning streak (largest 1-week decline since July 1, 2022). All about the Fed next week for bonds and currencies, with 75-bps expected – what comes after remains to be seen.

 

 

Macro

Up/Down

Last

WTI Crude

-1.18

87.90

Brent

-1.19

95,77

Gold

-20.80

1,644.80

EUR/USD

-0.0011

0.9951

JPY/USD

1.23

147.51

10-Year Note

0.075

4.014%

 

 

Sector News Breakdown

Consumer

·     Retailers: another big online tech giant bites the dust as AMZN said that it could just break even in Q4 while analysts were expecting more than $5 billion in operating profit and holiday sales of $140B-$148B vs. ests on revenue of $155.09B; AWS misses expectations with sales of $20.54B growing 27.5% y/y but was the lowest growth rate dating back to 2014 and below est. $21.2B; DECK Q3 revenue growth of +25% constant-FX (vs. consensus up mid-to-high teens), and EPS of $3.80 (vs. consensus $3.68) and reiterated FY as-reported revenue and EPS guidance; COLM Q3 EPS $1.80 vs. est. $1.67; Q3 revs $955.0M vs. est. $962.7M; backs FY22 EPS view of $5.00-$5.40 (est. $5.16) and backs FY22 revenue view, but qtrly inventories increased 47% to $1,056.9B; BBBY said to sell up to additional $150 mln of shares in "at-the-market" (ATM) program

·     Consumer Staples: CL Q3 adj EPS $0.74 vs. est. $0.73 and revs $4.46B vs. est. $4.47B; Q3 gross profit margin 57.2%, down 220 bps, raises FY22 organic sales growth view to 6%-7% from 5%-7%; sees FY22 company net sales growth to be in middle of 1% to 4% range; CHD Q3 EPS and sales top consensus but guides Q4 EPS $0.58-$0.62 below est. $0.72 and narrows year sales view; CVGW announced the divestiture of its Limoneira position for gross proceeds of $18.5M; NWL lowers full-year 2022 net sales and profit forecasts as inflation-hit consumers rein in spending

·     Restaurants: BLMN Q3 adj EPS $0.35 vs. est. $0.34 and revs $1.06B vs. est. $1.05B and comp sales rose 1.4%, just below the 1.8%, but expects EPS to range from $1.05 to $1.15, down from prior guidance of $1.11 to $1.22, as higher revenue is offset by higher inflation; TXRH Q3 EPS of $0.93 was higher than $0.89 consensus on co-owned SSS growth of 8.2% (vs. 6.1% cons.) and domestic franchised SSS growth of 6.7% (vs. 4.8% cons). Average check growth was 7.7%, including 0.5% of mix shift and 7.2% menu pricing, and traffic was 0.5%

 

Energy. Industrials and Materials

·     E&P and Majors: top majors report earnings today as XOM Q3 adj EPS $4.45 vs. est. $3.79; Q3 revs $112.07B vs. est. $115.6B; raises quarterly dividend to 91c per share; company spent $5.73 billion on new oil and gas projects last quarter, up 24% from a year ago, and remains on track to hit an investment Target of $21B-$24B; CVX Q3 adj EPS $5.56 vs. est. $4.81; Q3 revs $66.64B vs. est. $58.22B; reports Q3 U.S. upstream earnings $3.4B and reports Q3 U.S. downstream earnings $1.29B; worldwide net oil-equivalent production was 3.03 mln barrels per day in q3 2022; PXD delivered a modest earnings beat with no major surprises after the close, and left major guidance components unchanged

·     Aerospace & Defense: BAH posts Q2 results that top estimate and raises FY23 revenue and non-GAAP EPS forecasts citing momentum in its VoLT (velocity, leadership, technology) strategy; LHX downgraded to Market Perform from Outperform at Raymond James citing the stock’s recent outperformance, lack of identifiable catalysts, and several factors negatively impacting sales

·     Industrial & Machinery: in waste, CWST reported 3Q adj EBITDA of $75.0M, which comfortably beat our estimate consensus of $68.6M, driven primarily by revenue, with margins coming in line; RSG reported 3Q22 adj. EBITDA of $1.05B, which beat consensus of $977M driven by both revenue and margins. The strength on the top line was broad-based as average yield of 5.6% ticked up 60 bps sequentially and volume of 2.2% came in well above our estimate; in machinery, TEX increased its 2022 guidance to $4.00-$4.20 from prior $3.80-$4.00 after Q3 EPS/rev beat

·     Metals & Materials: in steel sector, US Steel (X) achieved 3Q adj EBITDA of $848M compared to mid-September guidance of $825M, but lowered guidance for Q4 Ebitda; in chemicals, EMN slashes FY22 EPS view to $8.05-$8.35 from $9.50-$10.00 (est. $8.75) after beating for Q3; LYB posted Q3 Ebitda and revs that missed consensus ests; Shares of copper miners fall (FCX) as copper slides after touching its highest in nearly three weeks on Wednesday as a strengthening dollar and new COVID-19 flare ups in China, weigh on industrial metals

·     Utilities & Solar: FSLR missed both revenue and profitability expectations by a wide margin and lowered 2022 guidance; JKS Q3 EPS $0.90 tops estimates of $0.41 while total revenue of 19.52 bln yuan ($2.74 bln), up 127.8% on-year due to an increase in solar module shipment; PCG 35M share Block Trade priced at $14.90

 

Healthcare

·     Pharma movers: ABBV mixed Q3 as EPS of $3.66 beats $3.57 est. but revs of $14.81B misses the $14.9B estimate, raises quarterly dividend to $1.48 from $1.41 and narrows year EPS view to $13.84-$13.88 from $13.76-$13.96 (est. $13.86) – Q3 U.S. Humira net revenues $4.956B, up 7.4%; VRTX reported $2.33B (+6% q/q; +18% y/y) in 3Q22 WW Cystic Fibrosis (CF) sales, above Street $2.23B estimates, driven by Trikafta/Kaftrio demand, uptake, and label expansion into younger CF patients while raised 2022 sales guidance to $8.8-$8.9B

·     Biotech movers: GILD Q3 sales above expectations, 2022 guidance raised prompts upgrade to Overweight from Neutral at Piper and raise tgt to $96 from $79, as multiple roadblocks have cleared for Gilead’s HIV and oncology franchises, providing greater visibility on future revenue growth; SGEN revenue was 11% higher than cons. while EPS was a miss (-$1.03 vs cons. of -$0.96) largely driven by higher R&D costs; BIIB slips after a report by STAT News said death of patient in closely watched Alzheimer’s trial for lecanemab raises concern about risk for some groups; PTCT shares fall following negative initial feedback from FDA on Translarna, coming on the heels of a partial clinical hold for their Huntington’s splice modulator, along with earnings

·     MedTech Equipment: EW slides as reported Q3 revs miss ($1.319B vs. est. $1.333B), near the bottom of the $1.30-$1.37B guidance range driven by lower TAVR results, as U.S. hospital staffing challenges persisted; RMD Q3 revenue beat consensus while EPS missed in F1Q23 as supply chain constraints improved sequentially; DXCM reported $769.6M in Q3 revenue (+18.5% y/y rep., +20% y/y org.), ~$19M above consensus and EPS a $0.04 beat driven by strength in U.S. sales as domestic revenue growth of 17% y/y

·     Healthcare Services: DVA slides as reports Q3 profit that missed ests (EPS $1.45 vs. est. $1.77) citing labor pressure and as it closed centers due to a decline in patient visits due to COVID-19 and lowers its FY22 adjusted profit outlook to $6.20-$6.70 from $7.50-$8.50

 

Technology, Media & Telecom

·     Hardware & Services: AAPL topped expectations on revenue and earnings with the help of Macs selling at a record pace during the back-to-school season, which outweighed a slight miss on iPhone sales – Q4 revs rose 8.1% y/y to $90.10B vs. est. $88.90B; Q4 products revs rose 9% y/y to $70.96B, Mac revs rose 25% y/y to $11.51B (better), iPad revs fell -13% y/y to $7.17B; SSNC results missed expectations as economic uncertainty resulted in weaker trends and reduced the full-year outlook on the top and bottom line

·     Media, Internet: Elon Musk completed his Twitter purchase, fires CEO and other top execs – new regime began today; PINS MAU accelerated Q/Q returning to 3Q21 levels growing 12M Q/Q to at 445M with UCAN users up for the first time since 1Q21 to 95M – Q3 adj EPS $0.11 vs. est. 0.06; Q3 revs rose 8% y/y to $685M vs. est. $666.71M

·     Semiconductors: INTC posted strong 3Q results, benefiting from customer pull-ins ahead of 4Q price increases, while 4Q guidance was below expectations as PC demand deteriorates, enterprise weakens, and China remains weak – stepped up cost cutting plans (INTC was upgraded at Barclay’s); Apple supply chain active (AVGO, CRUS ) after Apple reported iPhone revenues slightly below expectations, due to FX headwinds and supply constraints related to stronger than expected demand for the iPhone 14 Pro series; MPWR reported 3Q22 results that slightly beat revenue and NG EPS consensus estimates, while GM was in-line but guides revenue below consensus for the first time in 14 Qs

·     Telecom movers: TMUS posted impressive results and raise its guidance in the face of a relatively strong competitive environment and weakening macro – said expects to add between 6.2M-6.4M net monthly-bill paying subscribers in 2022, up from a prior forecast of 6M-6.3M; EGHT cut its revenue guidance for the full year; the guidance missed the average analyst estimate; CHTR Q3 residential internet customers increased by 61,000, vs an increase of 243,000 customers y/y

_________________________________________________________________

Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.

Live Trading

Open an Account

Paper Trading

Register